Visual And Anatomical Outcomes of Pars Plana Vitrectomy in Refractory Diabetic Macular Edema
暂无分享,去创建一个
[1] K. Bartz-Schmidt,et al. Interferon Alpha for Refractory Pseudophakic Cystoid Macular Edema (Irvine-Gass Syndrome) , 2020, Ocular immunology and inflammation.
[2] S. El-Baha,et al. Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema , 2019, Journal of ophthalmology.
[3] Lihteh Wu,et al. Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment , 2019, Taiwan journal of ophthalmology.
[4] I. Chatziralli,et al. Treatment of Macular Edema after Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane Using Intravitreal Dexamethasone Implant: Long-Term Outcomes , 2019, Ophthalmologica.
[5] P. Stavrakas,et al. Update in treatment of uveitic macular edema , 2019, Drug design, development and therapy.
[6] P. McGuire,et al. Novel therapeutic targets in diabetic macular edema: Beyond VEGF , 2017, Vision Research.
[7] M. Yaseri,et al. Outcomes of vitrectomy, membranectomy and internal limiting membrane peeling in patients with refractory diabetic macular edema and non-tractional epiretinal membrane , 2016, Journal of current ophthalmology.
[8] Shibo Tang,et al. COMPARISON OF INTRAVITREAL TRIAMCINOLONE ACETONIDE VERSUS INTRAVITREAL BEVACIZUMAB AS THE PRIMARY TREATMENT OF CLINICALLY SIGNIFICANT MACULAR EDEMA , 2015, Retina.
[9] S. Kang,et al. Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments; 3-year results , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.
[10] M. Yaseri,et al. Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Refractory Diffuse Diabetic Macular Edema , 2010, Journal of ophthalmic & vision research.
[11] H. Lemij,et al. Foveal cone photoreceptor involvement in primary open-angle glaucoma , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[12] A. Ruby,et al. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. , 2005, American journal of ophthalmology.
[13] Ashraf M. Gad Elkareem,et al. Outcomes of pars plana vitrectomy for the treatment of persistent diffuse diabetic macular edema , 2018 .
[14] L. Young,et al. Current and Emerging Treatment for Diabetic Macular Edema , 2017, International ophthalmology clinics.
[15] A. Loewenstein,et al. Diabetic Macular Edema: Emerging Strategies and Treatment Algorithms. , 2017, Developments in ophthalmology.
[16] Judy E. Kim,et al. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice. , 2016, JAMA ophthalmology.